Exploiting Radiation Therapy to Restore Immune Reactivity of Glioblastoma
Glioblastoma (GBM) is among the most aggressive of brain tumors and confers a dismal prognosis despite advances in surgical technique, radiation delivery methods, chemotherapy, and tumor-treating fields. While immunotherapy (IT) has improved the care of several adult cancers with previously dismal p...
Main Authors: | Mara De Martino, Oscar Padilla, Camille Daviaud, Cheng-Chia Wu, Robyn D. Gartrell, Claire Vanpouille-Box |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.671044/full |
Similar Items
-
Activin A backs-up TGF-ß to promote regulatory T cells
by: Mara De Martino, et al.
Published: (2021-01-01) -
460 The immuno-metabolic enzyme FASN prevents anti-tumor immune responses in irradiated glioblastoma
by: Claire Vanpouille-Box, et al.
Published: (2020-11-01) -
Immunological barriers to immunotherapy in primary and metastatic breast cancer
by: Mara De Martino, et al.
Published: (2021-08-01) -
Immune Evasion Strategies of Glioblastoma
by: Seyed-Mostafa eRazavi, et al.
Published: (2016-03-01) -
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)
by: Lijie Zhai, et al.
Published: (2019-03-01)